University at Buffalo scientists will continue nearly three decades of groundbreaking research on a bacterium considered a key cause of the hallmark signs of chronic obstructive pulmonary disease (COPD).
Six outstanding University at Buffalo medical residents and fellows have been honored with 2013 Arnold P. Gold Foundation Humanism and Excellence in Teaching Awards.
Award-winning participants in the Department of Medicine’s inaugural Research Day are studying diverse topics, including burnout, cold medications, a new-found anti-bacterial agent and a better leukemia treatment.
The UB Clinical and Translational Science Institute showcased award-winning studies and novel technologies developed jointly by UB researchers and collaborators.
UB researchers have identified specific roles for two innate immune pathways that drive acute lung injury—findings that may lead to the first treatment or preventive strategy for the condition.
UB researchers will use a $1.6 million grant from the National Institutes of Health to develop the first vaccine against an understudied bacterium that causes at least 10 percent of middle ear infections in children.
The AIDS Center/Immunodeficiency Services Clinic at Erie County Medical Center has won the 2012 New York State Department of Health AIDS Institute Award for Excellence in Quality Performance.
Faculty in the Departments of Medicine, Physiology and Biophysics, Anesthesiology and Pharmacology and Toxicology were recognized at the Celebration of Faculty and Staff Academic Excellence.
Biomedical researchers have discovered a novel, previously unrecognized set of genes essential for the growth of potentially lethal drug-resistant bacteria.
A T35 training grant from the NIH is providing stipends for UB medical students to participate in mentored research projects this summer at UB and Roswell Park Comprehensive Cancer Center.
